Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Churning thru financings shares
View:
Post by 1wascallywabbit on Feb 09, 2015 11:24am

Churning thru financings shares

It looks like it is going to take a while to churn thru all the shares that are being sold due to being in the money from the last couple financings at 0.23 and 0.29 or so.

I guess they are locking in some profits, so we could be at this level for a while.

Hopefully the increased demand will soon make them sorry for their early exit.
Comment by DamnYankees on Feb 09, 2015 12:42pm
I could be waaaaay off base here but the near term catalyst of a BLA submission as well as the "value drivers" noted in the corporate presentation should be driving demand that would nullify any profit taking from the two financings that you speak of. It is not. If fact there is very little demand for shares above 30 cents. Why is the company valued at 1/5th or less than that of its ...more  
Comment by PSB on Feb 09, 2015 1:22pm
Damn Yankee, "Welcome to", the frustration and bewilderment we longterm shareholders have had to endure for all these years. Hears hoping that we may finally turn the corner in 2015 with more promising news/shareholder value, in the coming months.
Comment by IWillRetireSoon on Feb 09, 2015 1:52pm
For some inexplicable reason certain posters to this board think that insulting and negative comments about fellow shareholders, current management, the FDA  and the company itself will somehow improve the share price....   Don't let their nonsense impact you.  2015 will be a good year.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities